Ketoprofen CAS 22071-15-4 For Anti-Inflammatory Analgesic
Ketoprofen Basic information:
Name: Ketoprofen
CAS: 22071-15-4
MF: C16H14O3
MW: 254.28
Standard: USP
Purity: Pharmaceutical grade 99%
Appearance: white powder
chemical properties: White Crystalline Solid
Packing: 25KG / Fiber drum
Uses Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties.
Uses Anti-inflammatory; analgesic
Description
ketoprofen,drinking and other non-steroidal anti-inflammatory drugs used in conjunction, will increase the gastrointestinal side effects, but also cause the risk of ulcers.
ketoprofen, aspirin or other salicylic acid drugs with the same time, can not increase the efficacy of gastrointestinal side effects and increased incidence of bleeding tendency.
ketoprofen, anticoagulant with the use of increased risk of bleeding.
ketoprofen should not be used with methotrexate to prevent poisoning.
ketoprofen, probenecid and verapamil, nifedipine with the use, pay attention to reduce the dose; with digoxin with the time, pay attention to adjust the digoxin dose.
Uses for aryl alkyl acid compounds. With analgesic, anti-inflammatory and antipyretic effect. Anti-inflammatory effect than ibuprofen strong side effects, low toxicity. Oral easily absorbed from the gastrointestinal tract. After 1 dose, about o. 5 to 2 hours up to plasma peak concentration. And t 1/2 is 1.6 to 1.9 hours. In the blood and plasma protein binding strong. In the 24 hours from the urinary excretion rate of 30% to 90%. Mainly in the form of glucuronic acid excretion. For rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, joint hard spondylitis and gout, etc.
ITEM |
SPECIFICATIONS |
RESULTS |
IDENTIFICATION |
.IR: THE INFRARED SPECTRUM OF THE SAMPLE
CORRESPONDS TO THE STANDARD SPECTRUM. |
CONFORMS |
APPEARANCE |
LIGHT YELLOW TO YELLOW LIQUID |
CONFORMS |
RESIDUE ON IGNITION |
≤0.1% |
0.08% |
WATER |
≤0.2% |
0.13% |
TOTAL IMPURITY |
≤1.0% |
0.15% |
PURITY |
≥99.0% |
99.85% |
CONCLUSION |
THE RESULTS CONFORMS WITH ENTERPRISE STANDARDS |